Park GH, Park S, Kim H, Jung HA, et al. Prospective investigation of biomarker and resistance mechanism using longitudinal cell-free NGS in non-small cell lung cancer with EGFR exon 20 insertion treated with amivantamab. Eur J Cancer 2025;226:115631.
PMID: 40651388